Unified Patient and Physician Attribution possesses a transformational capability for the pharma industry given the current challenges of pharma companies. A main challenge is the consumption model in healthcare which is complex in comparison to other industries. This complexity is also seen in the data, making it difficult to link data streams and restricting theRead More
The Ipsos MMA (Marketing Management Analytics) service line has supported its global team throughout the global pandemic. Recently, the urgent need for medical supplies, vaccines, oxygen, PPE and other life-saving assistance to battle the virus became evident in India. Speed was of the essence as, every day, the dire situation was creating more pain, sufferingRead More
When the COVID-19 pandemic hit, the quick onset of social distancing and varied forms of shelter in place regulations impacted the pharmaceutical industry in a multitude of ways. Some of the biggest impacts seen included: all forms of personal sales activities were suspended; for all non-essential / critical therapy needs HCPs were requiring patients toRead More
It’s easy to lose touch in times like these. Consumer behaviors have changed. Some of this will be short-term while undoubtedly some changes will be longer-term. But brands will go on. Consumer preferences and loyalties will persist. How brands behave in these challenging times will play a large role in that equation. But how shouldRead More
Actioning and optimizing your commercial investments against the evolving recovery and consumer demand curve on a real-time basis Most marketing driven organizations are working through what will effectively be two major cross-waves of planning. The first wave is rolling in now and is all about maximizing revenue and profits for the balance of the yearRead More
At a time when many companies are considering staff reductions and furloughs, Ipsos MMA stands apart in its extensive recognition of top performers. During Q1 2020, as many as 17% of the MMA team received promotions in recognition of their excellence in client service as well as their own advancing skillset. Most senior among theseRead More
By Doug Brooks, EVP at Ipsos MMA It’s been an age-old debate between marketing and finance executives. What is the value of brand building initiatives and how can they be measured if an impact can’t be seen in the short-term, how do we know what the affect will be over the long-term? Without clear evidenceRead More
By Doug Brooks, EVP at Ipsos MMA In order to navigate their way through this crisis, executives across brands and countries are leveraging data-driven analytics to get ahead of the virus and “war-game” business options and outcomes. The outcome of this will enable them to chart courses to best reach consumers with the right timingRead More
We are reaching out to you as business partners to ensure that you know Ipsos MMA is taking the spread of COVID-19 extremely seriously. We are working hard to ensure that we are able to service your business while simultaneously taking all appropriate actions to protect our employees’ health and well-being. While the Coronavirus situationRead More
Establishing “Data Readiness” to Drive the Most Value from an MTA Capability By Robert Cardarelli, SVP at Ipsos MMA With all the changes in the digital and TV data landscape, the promise of standing up a robust multi- touch attribution (MTA) model has left marketers with several big questions. How do I get an attributionRead More